Actively Recruiting
Study of the Nervous Systems Role in Spontaneous Coronary Artery Dissection and Arterial Health
Led by Mayo Clinic · Updated on 2026-06-17
50
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
M
Mayo Clinic
Lead Sponsor
N
National Heart, Lung, and Blood Institute (NHLBI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
This research compares the function of the sympathetic nervous system and arterial health, including artery structure and mechanics, between people who have had spontaneous coronary artery dissection SCAD and healthy individuals matched by age and sex. The study aims to understand differences in neurovascular function related to SCAD. It is sponsored by Mayo Clinic and is observational in nature without randomization or blinding. Participants with a history of SCAD and healthy control participants will undergo a series of diagnostic tests to assess neurovascular function. These tests include arterial tonometry to measure arterial stiffness, echocardiograms for heart ultrasound images, carotid ultrasounds to image the carotid artery, elastography to assess artery elasticity, ankle-brachial index to evaluate peripheral artery blood flow, and microneurography combined with stress maneuvers to measure sympathetic nerve activity. During the study, participants will have baseline assessments of arterial thickness, arterial stiffness, baroreflex sensitivity, and sympathetic responses to stress. The study monitors these parameters to better understand the neurovascular systems role in SCAD. Participation involves diagnostic testing without treatment intervention, and the study is expected to complete by August 2027.
CONDITIONS
Brief Title
A Study to Analyze the Role of Sympathetic Nervous System in Spontaneous Coronary Artery Dissection
Who Can Participate
Eligibility Criteria
You may qualify if you...
- For SCAD patients: history of SCAD confirmed by coronary angiography or cardiac computed tomography angiography
- For healthy controls: no history of cardiac disease
- Female sex
- Age 18 years or older
You will not qualify if you...
- Pregnancy
- Known or suspected unstable cardiac condition within 4 weeks of the study
- Active treatment with anticoagulation or dual antiplatelet therapy
- Prisoner
Research Team
P
Pamela Engrav
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here